Fredrik.Enlund@gu.se Sahlgrenska universitetssjukhuset



Similar documents
The Diagnosis of Cancer in the Pathology Laboratory

Immunohistochemistry of soft tissue tumors

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America

How To Get A Cell Print

Interesting Case Review. Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA

Nuovi Scenari in Oncologia. G. Zoppoli X-Files in Nutrizione Clinica e Artificiale, 08/06/2012

Breast and Lung Cancer Biomarker Research at ASCO: Changing Treatment Patterns

Nuevas tecnologías basadas en biomarcadores para oncología

Oncology Insights Enabled by Knowledge Base-Guided Panel Design and the Seamless Workflow of the GeneReader NGS System

Targeted Therapies in Lung Cancer

Molecular Diagnostics in Thyroid Cancer

Targeted Therapy What the Surgeon Needs to Know

Seattle. Case Presentations. Case year old female with a history of breast cancer 12 years ago. Now presents with a pleural effusion.

Médecine de précision médecine personnalisée en Oncologie. Fabien Calvo, Directeur Recherche et Innovation, INCa, Directeur ITMO Cancer, AVIESAN

targeted therapy a guide for the patient

Opportunities and Challenges in Translating Novel Discoveries into Useful Clinical Tests

Molecular Diagnosis of Gastrointestinal Tumors

March 19, Dear Dr. Duvall, Dr. Hambrick, and Ms. Smith,

Update in Hematology Oncology Targeted Therapies. Mark Holguin

ncounter Leukemia Fusion Gene Expression Assay Molecules That Count Product Highlights ncounter Leukemia Fusion Gene Expression Assay Overview

Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing

Corporate Medical Policy

Molecular Stratification of Cancer in the

Applications of comprehensive clinical genomic analysis in solid tumors: obstacles and opportunities

ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)

Cancer. 9p21.3 deletion. t(12;21) t(15;17)

Diagnosis of Mesothelioma Pitfalls and Practical Information

DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE

MetAction actionable targets in cancer metastasis from bed to bench to byte to bedside

Understanding series. new. directions LungCancerAlliance.org. A guide for the patient

Genomic Medicine Education Initiatives of the College of American Pathologists

What is New in Oncology. Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals

Future Directions in Clinical Research. Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center

Appendix 2 Molecular Biology Core Curriculum. Websites and Other Resources

Successes and Limitations of Targeted Cancer Therapy in Lung Cancer

High-quality genomic DNA isolation and sensitive mutation analysis

Corporate Medical Policy Molecular Markers in Fine Needle Aspirates of the Thyroid


Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs

White paper Evaluation of BRAF (V600E) Mutation by Immunohistochemical Staining with anti-braf V600E (VE1) Antibody: A Comparison with Sanger

Data Analysis for Ion Torrent Sequencing

Translocation Renal Cell Carcinomas

Craig Hallum Conference Investor Presentation

Tumor Patterns. Common Morphologic Patterns in Soft Tissue Tumors. Update on Lipomatous Tumors. MFH-like. Highly cellular spindle cell pattern

What is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:

For years, drug developers have used histology as the

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle

Genetic Testing in Research & Healthcare

BRAF in the diagnostic evaluation of thyroid nodules

Molecular analyses of EGFR: mutation and amplification detection

Malignant Lymphomas and Plasma Cell Myeloma

A disease of populations of cells that live, divide, invade and spread without regard to normal limits

Small Round Cell Tumors of Bone and Soft Tissue: An Update Los Angeles Society of Pathologists November 11, 2014

Non Small Cell Lung Cancer: Scientific Discoveries and the Pursuit of Progress

Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach

Future Oncology: Technology, Products, Market and Service Opportunities

Cytogenetics for the Rest of Us: A Primer

MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS

New Clinical Research & Care Opportunities Through Big Data Informatics

Molekylært målrettet medicinsk kræftbehandling for klinikere principper og metoder

Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer

A clinicians view on NGS of (lung) cancer

MODERN IMMUNOHISTOCHEMISTRY

Report series: General cancer information

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

Using genetic biomarkers to pre-identify oncology patients for clinical trials

Pharmacogenomic Approaches. Luis Paz-Ares Hospital Universitario Virgen del Rocio Seville, Spain

The following information is only meant for people who have been diagnosed with advanced non-small cell

BAP1 germline mutations A new Cutaneous Nevus Melanoma Syndrome. Thomas Wiesner

Leukemias and Lymphomas: A primer

Genomic Analysis of Mature B-cell Malignancies

Clinical Use of Molecular in the Treatment of Lung Cancer

Guidelines and Quality Assurance for Acquired Cytogenetics

La diagnostica molecolare nelle neoplasie colo-rettali. A do Scarpa. U iversita di Vero a

Update on Mesothelioma

Clinical Genetic Molecular Biology Scientist Program

Case based applications part III

How can we generate economic value from personalized medicine and big data analysis?

Contents. molecular biology techniques. - Mutations in Factor II. - Mutations in MTHFR gene. - Breast cencer genes. - p53 and breast cancer

The Biological Basis of Cancer. Annie Young, Professor of Nursing, University of Warwick, University Hospitals Coventry and Warwickshire

PROGNOSIS IN ACUTE LYMPHOBLASTIC LEUKEMIA PROGNOSIS IN ACUTE MYELOID LEUKEMIA

Haematopoietic Chimerism Analysis after Allogeneic Stem Cell Transplantation

Inspira (Vineland/Woobury) Open Clinical Trials as of December 16, 2015

PrimePCR Assay Validation Report

CML. cure. A Patient s Guide. Molecular Biology Diagnosis Stem Cell Transplant Monitoring New Drugs Questions to Ask and More

Bovine heart LSA, Case #

Transcription:

Fredrik.Enlund@gu.se Sahlgrenska universitetssjukhuset 1

Techniques for sarcoma diagnostics Molecular Pathology of Solid Tumors Uppsala 120924 Klinisk Molekylär Patologi Klinisk Patologi och Cytologi

Gene PDGFRA Tumor GIST KRAS Colon Lung BRAF Papilliar Thyreoidea Malign Melanoma EGFR Lung RET MEM2 Molecular pathology Sahlgrenska Univ. Analyses TCR IgH Fusion genes Lymfoma Lymfoma Sarcoma Lymfoma Lung HER2 Breast Microsatellit repeat Ventricle KIT GIST Malign Melanoma Urovysion

Gene PDGFRA Tumor GIST KRAS Colon Lung BRAF Papilliar Thyreoidea Malign Melanoma EGFR Lung RET MEM2 Molecular pathology Sahlgrenska Univ. Analyses TCR IgH Fusion genes Lymfoma Lymfoma Sarcoma Lymfoma Lung HER2 Breast Microsatellit repeat Ventricle KIT GIST Malign Melanoma Urovysion

Chromsomal translocations in disease http://en.wikipedia.org

Fusion genes are often tumor specific and therefore of diagnostic value FUS EWSR1 TAF15 DDIT3 CREB3L1,2 ERG ZNF384 FLI1 ETV1 ETV4 FEV ATF1 WT1 ZNF278 NR4A3 Myxoid/ Round cell-liposarcoma Low grade fibromyxoid sarcoma Acute myeloid leukemia Acute lymphoblastic leukemia Ewing s sarcoma Angiomatoid malignant fibrous histocytoma Clear cell sarcoma Desmoplastic small round cell tumor Extraskeletal myxoid chondrosarcoma

Fusion genes EWSR1 FLI1 Normal RNA Fusion gene RNA 100-200 bases RT-PCR produkt 7 Fusionsgener i Sarkomdiagnostiken

One sarcoma, many transcripts Example: Ewing sarcoma t(11;22) EWSR1 EWSR1 FLI1 FLI1 t(21;22) EWSR1 ERG RT-PCR t(7;22) EWSR1 ETV1 t(17;22) EWSR1 ETV4 Kromosom 22 EWSR1 FISH 8 Fusionsgener i Sarkomdiagnostiken

Chromosomal translocation vs mutation detection Sarcoma GIST (Kit ex 9,11,13) http://ghr.nlm.nih.gov FISH RT-PCR (RNA) tumor specific DNA In all cells (heterogeneity)

Laboratory practice Middle needle biopsies 2012-10-16 Fredrik.Enlund@gu.se Initial FISH and then RT PCR (confirming)

. FISH-technique split signal / break-a-part Break point Chromosome region 2x100 cells counted

RT-PCR technique Paraffin material RNA cdna PCR Gel separation

RNA-extraction The old way RNA steamer Today, RNeasy FFPE-kit (Qiagen)

Targeted OneStep RT-PCR FLI1-primer Reverse EWS-primer Forward Fusionsgener i Sarkomdiagnostiken 14

Targeted OneStep RT-PCR FLI1-primer Reverse Gene specific Higher sensitivity Increased amplification EWS-primer Forward Fusionsgener i Sarkomdiagnostiken One Onestep per transcript variant 15

Result Patient Tonsill Pos.Ctrl PP Patient Tonsill Pos.Ctrl PP Patient Tonsill Pos.Ctrl PP EWSR1-FLI1 typ 1 EWSR1-FLI1 typ 2 EWSR1-ERG Patient Tonsill Pos.Ctrl PP EWSR1 FLI1 B-actin EWSR1 FLI1 16 Fusionsgener i Sarkomdiagnostiken

Fusion genes in diagnostics at KMP, Sahlgrenska University hospital EWSR1-FLI1 typ 1/2 Ewingsarkom EWSR1-ERG Ewingsarkom SYT-SSX typ 1/2 Synovialsarkom EWSR1-ATF1 Clearcellssarkom EWSR1-CHN/TEC Extraskeletal Myxoidchondrosarkom TAF2N-CHN Extraskeletal Myxoidchondrosarkom FUS-DDIT3 typ 1/2 Myxoidliposarkom/Rundcellsliposarkom EWSR1-DDIT3 Myxoidliposarkom/Rundcellsliposarkom EWSR1-WT1 Desmoplastisk small round cell sarkom PAX3-FOXO1A (FKHR) Alveolär Rhabdomyosarkom PAX7-FOXO1A (FKHR) Alveolär Rhabdomyosarkom ETV6-NTRK3 Congenital fibrosarkom COL1A1-PDGFB Dermatofibrosarkom protuberans (DFSP) (FISH-probes)

Centralisation for Ewing sarcoma diagnostics? Sahlgrenska Univ. Hosp. Göteborg

R&D project in Sarcoma first and second approach

Our future challange The right drug for the right patient at the right dose Genetics Morphology Farmaco genetics Individually tailored medication BIOMARKER(S) It s in our genes 2012-10-16 Fredrik.Enlund@gu.se

Aim: To look for well known biomarkers for targeted treatment in sarcoma Target genes EGFR1 BRAF NRAF KRAS ckit PDGFRA JAK2 HER2 PIK3

Enhanced mutation detection 1st approach When availible ARMS or sensible techniques Macro disection of tumor material Material from # 39 FFPE Ewing Sarcomas 2nd approach

Aim: To Study Circulation Tumor Cells (CTC) in Ewing sarcoma patients 2nd approach

Disappointing 1st approach No significant mutations detected in none of the analysed tumors (maybe not surprizing fusion genes) 2nd approach Not completed

Lack of other knorrs at the end

Co-workers at KMP,Sahlgrenska? Carola Andersson Josefin Andersson Anders Edsjö Tina Ekviden Carina Karlsson Helene Sjögren Anita Viskari R&D sponsored by Johan Janssons forskningsstiftelse för sarkom 2012-10-16 Fredrik.Enlund@gu.se

Thanks for your attention!